Grindr Inc. completed its acquisition of PurposeMed Inc., the parent company of HIV prevention telehealth provider Freddie, on November 2, 2026, paying $250 million in cash and stock and putting a prescription health service inside an app that still earns close to a fifth of its revenue from advertising. The deal adds clinical, telehealth, pharmacy and patient-support operations in the United States and Canada to a dating and social app built, in its own words, "by gay people for gay people," and it closes 33 days after the agreement was first announced on September 30.

In Short

Grindr, a dating app used by nearly 16 million people a month, has bought Freddie, a company that helps people get PrEP, a medicine that prevents HIV. That matters because Grindr makes part of its money from ads and has been fined, and has agreed to a settlement, over user data that went to advertising partners years ago, including what UK claimants alleged was their HIV status. Users in the US and Canada can now reach Freddie from inside the app, and the open question is whether, and how, Grindr will keep patient information apart from its advertising business.

What Grindr paid

The headline price is $250 million: $190 million in cash and $60 million in Grindr common stock, according to the company. A further $70 million in cash is possible if PurposeMed hits performance targets for 2027, with any payout due in 2028. The announcement does not specify those targets. If they are met in full, the total consideration rises to $320 million, and the cash component to $260 million.

None of the terms moved between signing and closing. The September 30 announcement carried the same split, the same $70 million earnout and the same 2028 payment date, and said the boards of both companies had approved the transaction and that it was expected to close in the fourth quarter of 2026, subject to closing conditions it did not list.

What the completion announcement does not say is almost as telling for investors. It gives no share count for the $60 million stock portion and no price at which those shares were valued. It does not name a financing source for the cash. Grindr points readers instead to a shareholder letter dated September 30, 2026, on its investor relations website.

The price can be set against Freddie's own expectations. In the September 30 announcement, Grindr said Freddie expected 2026 revenue of more than $80 million and more than $10 million in adjusted EBITDA. On those floors, PPC Land calculates that the $250 million upfront price represents at most about 3.1 times expected 2026 revenue and at most 25 times expected adjusted EBITDA. With the full earnout, the revenue multiple reaches at most 4 times. Because both of Freddie's figures are stated as minimums, the true multiples are lower than these ceilings.

What Freddie brings

Freddie is a telehealth provider of PrEP, short for pre-exposure prophylaxis, the medication that prevents HIV infection. According to the September 30 announcement, it has helped more than 55,000 patients in Canada and the United States get PrEP and now serves patients in all 50 US states. Grindr also said then that the acquisition would have an immaterial impact on its 2026 financial results.

George Arison, chief executive of Grindr, framed the purchase as a shortcut. "The acquisition gives us a profitable business, an experienced team, and clinical and pharmacy capabilities that would take us at least two years to build ourselves," he said in the November 2 announcement.

The word "profitable" deserves a closer look. Freddie's guidance was for adjusted EBITDA, a non-GAAP measure, not net income. At the stated minimums, PPC Land calculates an adjusted EBITDA margin of about 12.5%. Grindr's own guidance, raised in August to about $540 million in 2026 revenue and $232 million in adjusted EBITDA, implies a margin of roughly 43% on the same basis, by PPC Land's calculation. Grindr said in September that Freddie's current margins reflect early-stage growth investments, including infrastructure to build its US platform. The completion announcement's own safe-harbor language, meanwhile, lists "anticipated profitability" among the forward-looking statements that may not come true.

The structure of the clinical side is also worth reading closely. Grindr acquired PurposeMed "inclusive of the Freddie brand and its partnerships with affiliated clinical networks." The announcement describes those networks as partners, not as clinics Grindr now owns, and it does not name them.

The patient numbers behind the ambition

Arison went further than the deal terms. "Together, we have an opportunity to prevent thousands of new HIV infections a year while building a major new source of profitable growth for Grindr," he said.

Freddie's own estimate, published by Grindr on September 30, is more modest. It put the number of new HIV transmissions prevented by its patients' PrEP use at approximately 385 a year, saving the Canadian and US health systems a combined $270 million to $580 million in future treatment costs annually. Reaching "thousands" would require Freddie's patient base to grow severalfold. Grindr's broader target, also from September, is to connect 10 million LGBTQ+ people worldwide to HIV prevention directly through the app by 2028, a goal far larger than a service that today operates only in two countries.

Grindr cited other figures in September to describe the gap it wants to fill: about 650,000 people in the United States on PrEP, against an estimated 2.2 million who could benefit from it, with PrEP use among gay and bisexual men growing by roughly 10% a year.

How it appears in the app

For now, the integration is an entry point. "Eligible Grindr users in the US and Canada can connect with Freddie through the Health center in the Grindr app today," the company said on November 2. A deeper product is promised but undated: "Over time, Grindr plans to build a more integrated experience that makes it easier to learn about, access, and manage HIV prevention care."

Grindr describes the deal as establishing "PrEP access as the foundation of Grindr's broader health business," a new line it is building "alongside its core app and premium products." That health business has a name, Grindr Health, which the company says "brings together technology and clinical expertise to make it easier to access and manage health and wellness care." It is not Grindr's first move into health. The company reported distributing what it described as hundreds of thousands of free HIV self-test kits across four continents when it published its 2024 results.

The announcement does not explain which users are eligible, whether eligibility depends on age, location or account type, or whether the Health center is shown to users outside the two countries.

A dating app with an advertising business

For the advertising industry, the significance of the deal lies in where it lands. Grindr is not a health company that happens to have a community. It is a large, ad-supported mobile audience that is now adding a pharmacy and clinical business.

The company says it serves nearly 16 million average monthly active users. That figure has crept up steadily: Grindr reported 14.6 million in the third quarter of 2024, 14.9 million in the second quarter of 2025 and an average of about 15 million for full-year 2025.

Advertising has grown faster than the audience. Grindr's indirect revenue, which is mostly advertising, reached $74 million in 2025, up 37% from $54 million, with fourth-quarter growth driven primarily by programmatic demand, and the company named direct advertising and brand partnerships as a 2026 priority. In the second quarter of 2026, advertising rose 44% to $25 million, or 18.1% of total revenue of $138 million. Arison told investors in August that Grindr still faced significant challenges in getting advertisers to work with it directly, and management guided advertising back toward its historical share of about 15% of revenue in 2027.

Set those numbers beside Freddie's. If Freddie's 2026 revenue tops $80 million as forecast, PPC Land calculates that it will exceed the $74 million Grindr earned from advertising in all of 2025 and equal close to 15% of Grindr's guided 2026 revenue. In revenue terms, the health business Grindr has just bought is roughly the size of its entire advertising operation.

Arison's description of the strategic logic is explicit about what Grindr brings to the combination. "We can now combine those capabilities with Grindr's reach and daily relationship with gay men to bring more patients into care and accelerate the fight against the HIV epidemic," he said. A daily relationship with millions of users is precisely what makes Grindr attractive to advertisers. Whether that relationship will also drive patient acquisition for Freddie through in-app placements, prompts or targeting is not something the announcement addresses.

The data question the announcement does not answer

Grindr arrives at this deal with a record on health and sensitive data that few consumer apps share, and that record runs straight through the advertising supply chain.

Between July 20, 2018 and April 7, 2020, under its previous ownership, Grindr shared user data with between seven and ten advertising partners. Norway's data protection authority fined the company NOK 65 million on December 24, 2021. The Oslo District Court upheld the fine on July 1, 2024, and the Borgarting Court of Appeal dismissed Grindr's appeal on October 21, 2025, finding that the company acted intentionally. The data involved included advertising identifiers, IP addresses, device specifications, self-reported age and gender, GPS location and app identifiers. Under European rules, information that reveals a person's sexual orientation or health is special category data, which may not be processed by default unless a specific exemption, such as explicit consent, applies.

The British case went further on health. On September 2, 2026, Grindr agreed to pay £26 million to settle a group action in the High Court of England and Wales brought by about 12,000 users. The claim alleged that Grindr passed users' HIV status, along with advertising identifiers and location data, to advertising partners over the same 2018 to 2020 period. The settlement contains no admission of liability, and Grindr continues to dispute the allegations. It is payable in two instalments of £13 million, due by December 31, 2026 and March 31, 2027. The first falls due less than two months after the Freddie deal closed.

The consequences have spread beyond Grindr itself. On October 12, 2026, Datatilsynet fined Microsoft's Xandr NOK 92 million over the same Grindr data, finding that Xandr acted as a joint controller, that the data required explicit consent, and that Xandr did nothing to verify it. Data relayed through real-time bidding, the authority said, could reach potentially thousands of actors.

What happens to that kind of information once a user taps into the Health center? Against that background, the November 2 announcement is silent on every point a privacy regulator or a cautious advertiser would ask about. It does not say whether data generated in the Health center or by Freddie's patients will be kept apart from Grindr's advertising systems. It does not say whether PrEP-related activity will be used to target or measure ads, or whether Grindr will advertise Freddie to users based on their in-app behaviour. It does not describe which privacy policy governs a user who moves from a dating profile into a prescription service.

In the United States, HIPAA governs protected health information held by health care providers, health plans and the businesses that work on their behalf. It does not apply to consumer apps as such. That makes the boundary between Grindr's app and Freddie's clinical partners more than a technical detail, because it can decide which rules apply to the same piece of information. Canada adds its own federal and provincial privacy laws. The announcement does not say where Grindr draws the line.

The broader enforcement climate around health data in advertising is not easing. A federal jury in San Francisco found on August 4, 2025 that Meta violated the California Invasion of Privacy Act by collecting reproductive health data through the Flo period-tracking app's software development kit. On October 29, 2026, Federal Trade Commission staff sent warning letters to 25 companies marketing health plans, reminding them that civil penalties can reach up to $53,088 per violation. Neither case involves Grindr, but both show regulators and courts treating health signals in marketing as a live risk.

What remains unknown

Several facts that would let advertisers, investors and users judge the deal are missing from the completion announcement:

  • The number of Grindr shares issued for the $60 million stock portion, and the price used.
  • The 2027 performance targets that govern the $70 million earnout.
  • The names of the affiliated clinical networks and how patient records are held between them and PurposeMed.
  • Any data-handling commitments separating the Health center from Grindr's advertising products.
  • A timetable for the "more integrated experience" Grindr says it will build.

Grindr said on September 30 that it would give more detail on its 2027 outlook on its third-quarter earnings call in November. The November 2 announcement does not mention that call. The release also refers investors to the risk factors in Grindr's annual report for the year ended December 31, 2025 and in subsequent quarterly reports, and names among the forward-looking risks "our ability to successfully integrate PurposeMed's operations, team, and technology with Grindr."

For an app whose advertising business grew 37% in 2025 while regulators and courts have been examining what happened to its users' data since 2020, the integration Grindr is promising is not only an operational question. It is a test of whether a company can run an ad-supported social network and a prescription health service under one roof without the two sides sharing more than a front door.

Timeline

Summary

Who: Grindr Inc. (NYSE: GRND), led by chief executive George Arison, and PurposeMed Inc., the parent company of HIV prevention telehealth provider Freddie, together with Freddie's affiliated clinical network partners.

What: Grindr completed its acquisition of PurposeMed for $250 million, made up of $190 million in cash and $60 million in Grindr stock, with up to $70 million more in cash tied to 2027 performance targets. Freddie becomes the foundation of Grindr Health, and eligible users can reach it through the app's Health center. Freddie expected more than $80 million in 2026 revenue and more than $10 million in adjusted EBITDA.

When: The deal was announced on September 30, 2026 and completed on November 2, 2026. Any earnout is payable in 2028.

Where: Freddie operates in the United States, in all 50 states, and in Canada. Grindr serves nearly 16 million average monthly active users worldwide.

Why: Grindr says the deal gives it clinical and pharmacy capabilities it would otherwise need at least two years to build, and a new profitable growth line beside its subscriptions and advertising. For the marketing industry, it places a prescription health service inside an ad-supported app whose past sharing of user data with advertising partners led to fines in Norway, a £26 million UK settlement and a separate fine against Xandr, while the announcement says nothing about how patient data will be separated from advertising.